1

NAD+ 1g & Retatrutide - A UK Update

News Discuss 
The recent landscape of metabolic support in the UK is seeing significant interest in the synergy of high-dose NAD+ supplementation – often at 1000mg – and the novel GLP-1 receptor agonist Retatrutide (or https://000mg472486.2blogspot.com/profile

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story